Abstract. Chronic pain is a significant health problem which interferes with patients daily functioning and quality of life. Valid and reliable measures of pain-related interference are needed to provide adequate care to patients and monitor changes in pain and functioning over time. This study sought to evaluate the reliability and validity of a Portuguese version of the Brief Pain Inventory (P-BPI) interference scale. Two hundred and fourteen patients with chronic musculoskeletal pain completed the P-BPI, 0-10 NRS of pain intensity, Short Form-12 Health Status Questionnaire (SF-12), Hospital Anxiety and Depression Scale (HADS). The P-BPI demonstrated excellent internal consistency (Cronbach's alpha = .91) and showed moderate associations with the criterion measures (all rs .30 or larger), supporting its construct validity. Confirmatory factor analysis of the P-BPI items yielded a single factor, further supporting its construct validity. The results provide strong support for the reliability and validity of the P-BPI interference scale. Keywords: Portuguese Brief Pain Inventory, pain interference, reliability, validity.
, results in a complex set of somatic and psychosocial changes that undermines quality of life (Merskey & Bogduk, 1994; Miró et al., 2008; Pareja, 2008) . Chronic pain can come to dominate the patients and his/her family's lives, impacting mobility, muscular strength, daily routines, working ability, mood, interpersonal relationships, sleep, and satisfaction with life (Breivik, Collet, Ventafridda, Cohen, & gallacher, 2006; Miró et al., 2008; Morlion et al., 2008; Pareja, 2008; Tunks, Weir, & Crook, 2008) .
Based on a biopsychosocial perspective, and in order to provide adequate care and to be able to monitor changes in key pain-related variables over time, the IMMPACT consensus group (Dworkin et al., 2008) has argued that an adequate evaluation of chronic pain should include different dimensions of the pain experience. These include severity, location and pain's impact or interference on daily living (Crespo & Rodríguez, 2008; Dworkin et al., 2005) , among other medical, psychological and social aspects (Crespo & Rodríguez, 2008; Dworkin et al., 2005) . Thus, for both clinical and research purposes, valid and reliable measures of each of these dimensions of pain experience are needed.
The Brief Pain Inventory (BPI) (Cleeland & Ryan, 1994) Interference scale is one of the most commonly used measures used to assess pain-related interference and disability. It has proven validity (via correlation with criterion measures: between 0.48 and 0.67 with pain intensity; 0.34 and 0.57 with measures of global physical functioning; 0.41 and 0.52 with measures of global psychological functioning; 0.34 and 0.62 with measures of anxiety and depression) and reliability (Cronbach's alpha between 0.78 and 0.95) across multiple languages and cultural groups, and across a broad range of pain conditions (including cancer, multiple sclerosis, spinal cord injury, musculoskeletal conditions, diabetic peripheral neuropathy, herpes zoster and postherpetic neuralgia), for evaluating the impact of pain on daily life (Badia et al., 2003; Caraceni et al., 1996; Cleeland & Ryan, 1994; Kalyadina et al., 2008; Keller et al., 2004; Mendoza, Mayne, Rublee, & Cleeland, 2006; Osborne, Raichle, Jensen, Ehde, & Kraft, 2006; Poulos, gertz, Pankratz, & PostWhite, 2001; Radbruch et al., 1999; Raichle, Osborne, Jensen, & Cardenas, 2006; Saxena, Mendoza, & Cleeland, 1999; yun et al., 2004) . The factor structure found in the original study yielded a one factor solution and the same factorial structure have been supported in subsequent studies and in the translated versions (Badia et al., 2003; Caraceni et al., 1996; Cleeland & Ryan, 1994; Kalyadina et al., 2008; Radbruch et al., 1999; Saxena et al., 1999; yun et al., 2004) . Its validity and reliability have been established across a large number of languages, cultures and pain conditions. Its strengths also include its brevity, simplicity and easy administration and scoring even if administered verbally, making the BPI interference scale very useful in both research and clinical settings, enabling crosscountry and cross-cultural comparisons. Moreover, the BPI Pain Interference scale has also been recommended by the IMMPACT consensus group (Dworkin et al., 2008) as one of two validated measures of pain-related impact on functioning for both research and clinic purposes.
Two preliminary studies have examined the psychometric properties of the BPI Interference Scale for the Portuguese populations (Azevedo et al., 2007; Ferreira-Valente, Pais-Ribeiro, & Jensen, 2010) . These studies demonstrated that the P-BPI Interference scale has good reliability (Azevedo et al., 2007; Ferreira-Valente et al., 2010) and criterion validity (Ferreira-Valente et al., 2010) . However, additional research is needed to replicate these findings and confirm the factor structure in a sample of Portuguese individuals with chronic pain, as well as to provide further cross-cultural validation of the measure to enable use in cross-cultural research.
The purpose of this study is to provide further validation of the Portuguese version of the BPI Interference Scale to enable its use in clinical and cross-cultural studies. Based on previous research with the BPI in other samples, we hypothesized that: (1) a confirmatory factor analysis of the P-BPI interference items would yield one factor that explains a substantial portion of the variance in the items; (2) the internal consistency (Cronbach's alpha) of the Portuguese version of the BPI (P-BPI) would be good to excellent (above .80) (Nunnally & Bernstein, 1994) ; and (3) the concurrent validity of the P-BPI would be supported via a pattern of significant moderate to strong (i.e., .30 or larger) correlation coefficients with pain intensity ratings and with measures of physical and psychological functioning.
Methods

Participants
Two-hundred and fourteen patients, over 18 years old, with chronic musculoskeletal pain of seven health care institutions in northern and central Portugal completed the study protocol. The sample age ranged between 22 and 88 years old (M = 60.18, SD = 14.89), 64.7% were married or living with a significant other and 66.1% were female. Most participants had a history of chronic pain for at least two years (71.4%), and 38.2% reported having had pain for more than 10 years.
Measures
Demographic (e.g. age, sex, marital status, level of education, professional status) and pain history information (duration, location and cause) were assessed. Participants also rated their pain intensity in its maximum, minimum and on average during the previous 24hours on 0 to 10 Numerical Rating Scales (NRS). Research supports the validity of the NRS as a measure of pain intensity .
The P-BPI interference scale assesses pain interference across seven daily life activities (i.e. general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life) on 0 to 10 numerical scales. Research supports the validity and reliability of BPI across different cultures and languages (Cleeland & Ryan, 1994 ). Author's permission for use of the BPI was obtained.
The Portuguese SF-12 (Pais-Ribeiro, 2005) was used to assess perceived health status. The SF-12 is scored to assess two health status domains: Physical (Physical Component Summary, PCS) and Psychological (Mental Component Summary, MCS) functioning. The Portuguese version has shown satisfactory reliability and validity (Pais-Ribeiro, 2005) . The Portuguese version of the Hospital Anxiety and Depression Scale (HADS; Pais-Ribeiro et al., 2007) was used as measure of psychological functioning. It asks respondents to rate the severity of 14 depressive or anxiety symptoms on 4-point Likert scales, and has demonstrated good reliability and validity (Pais-Ribeiro et al., 2007) .
Procedures
After signing a consent form, all participants were invited to complete all of the study measures. Subjects who were unable to read or write were assisted by the investigators in completing the measures.
Data Analysis
Statistical analyses were performed using software PASW Statistics 18. Means and standard deviations for study variables were computed for descriptive purposes. We then performed confirmatory factor analysis (CFA) using EQS V6.1 (Bentler & Wu, 1995) to test a hypothesized one-factor model for the seven BPI interference items, using the Comparative Fit Index (CFI) and Standardized Root Mean Square Residual (SRMR) to determine fit (Byrne, 2005) . Finally, internal consistency of the P-BPI was assessed by computing a Cronbach's alpha, and construct validity was evaluated by computing Pearson correlation coefficients between the total P-BPI pain interference score and the criterion measures. & Keller, 1998) . On the other hand, mean scores on the HADS, for anxiety (M = 7.69, SD = 4.13) and depression (M = 6.37, SD = 3.77), were suggestive of mild anxiety similar to individuals with a variety of medical disorders, and normal ratings of depressive symptoms (Pais-Ribeiro et al., 2007) .
The combinational indices for the CFA, in our study, supported a one-factor solution, χ 2 (14) =72.54, (p < 0.001), CFI = 0.91; SRMR = 0.06 (Bentler & Bonett, 1980; Hu & Bentler, 1999) . The P-BPI demonstrated an excellent internal consistency in our sample, with an alpha coefficient of 0.91, which is comparable to the internal consistency values from other samples (see Table 2 ). The values of the alpha if individual items are deleted were comparable to the overall alpha, suggesting that no item detracts from the reliability of the measure. 
Discussion
The findings provide strong support for the reliability and validity of the Portuguese BPI Interference scale. The Cronbach's alpha of 0.91 indicates excellent internal consistency (Nunnally & Bernstein, 1994; Pais-Ribeiro, 2008) . This value, similar to those found in the original scale (Cleeland & Ryan, 1994) , and is higher than the one found in the previous studies for the P-BPI interference scale (Azevedo et al., 2007; Ferreira-Valente et al., 2010) . The high level of internal consistency is also supported by the results of the factor analysis, which provide supports for a single factor (Bentler & Bonett, 1980; Hu & Bentler, 1999) .
The confirmatory factor analysis yielding a single factor is consistent with and replicates the findings of the original study as well as previous studies using other translated versions of the BPI Interference scale (Badia et al., 2003; Caraceni et al., 1996; Cleeland & Ryan, 1994; Kalyadina et al., 2008; Radbruch et al., 1999; Saxena et al., 1999; yun et al., 2004) . This consistent finding suggests the possibility that the domain of pain interference may be a unitary domain. However, it remains possible that, even if the specific BPI Interference items assess a single domain, pain interference may be a multidimensional construct, and the BPI items may not adequately reflect this construct. Recently, for example, yamashiro and colleagues (2011) described a new measure of pain interference -the Pain Disability Assessment Scale (PDAS) -that assesses three distinct pain interference domains: (1) interference with social activities; (2) interference with activities of daily living, and (3) interference with activities that require the use of the low back. It is possible that the consistent support for a single factor solution to the BPI may be associated with its relative brevity and lack of items that reflect some of the interference domains assessed by lengthier measures. The question regarding whether pain interference is best thought of as a single-or multiple-domain construct may be particularly important if different pain interference domains turn out to have different associations with other key pain-related variables (for example, interference with social activities may have stronger associations with measures of psychological functioning, while interference with daily activities might have stronger associations with disability) (yamashiro et al., 2011) . Thus, although the BPI is brief, which makes it useful in settings where assessment burden may be an issue, it may lack content validity for assessing more than one pain interference domain. To the extent that clinicians or researchers may want or need to assess more than one interference domain, a measure such as the PDAS might be considered.
All of the correlations coefficients between P-BPI interference scale and criterion measures support the criterion validity of the Portuguese version of the BPI interference scale. Overall, the coefficients are consistent with the guidelines derived from previous studies (Keller et al., 2004; Mendoza et al., 2006; Osborne et al., 2006; Poulos et al., 2001; Radbruch et al., 1999; Raichle et al., 2006) , and with the guidelines proposed by Raichle and associates (2006) , suggesting that measures of pain interference should be at least moderately associated (correlation coefficients greater than 0.30) with pain intensity and physical and psychological functioning. Consistent with previous research anxiety (FerreiraValente, Pais-Ribeiro, Keller et al., 2004; Mendoza et al., 2006; Osborne et al., 2006; Poulos et al., 2001; Radbruch et al., 1999; , pain interference is strongly correlated with pain intensity, physical and psychological functioning and mood, with patients with higher pain interference having higher levels of pain intensity, worse physical and psychological functioning, and higher levels of depression and anxiety. These findings suggest the importance of pain interference as a predictor of psychological functioning and patients' quality of life and health perception. Considered together with previous studies conducted in different pain conditions, languages and cultures, the results also suggest that the concept and effects of pain interference might generalize across countries.
One important limitation of this study was the use of a cross-sectional design. Because all measures were administered only once, we were not able to evaluate the test-retest stability of the P-BPI over time. Second, we could not determine how representative of the population of patients in Portugal with chronic musculoskeletal pain the sample is. Thus, future research is needed to help establish the generalizability of the findings. Finally, we administered only one measure of pain-related interference in this study, which does not allow us to establish the convergent validity of the measure. Additional research addressing this issue is, therefore, needed.
Conclusion
Despite the study limitations, the findings support the use of the P-BPI in clinical samples. The availability of a validated measure of pain interference for use in individuals who speak Portuguese will contribute to the ability of Portuguese researchers to determine the effects of treatments on the critical outcome domain of pain interference, and compare findings among patients in Portugal to those from samples in other parts of the world.
